Synexus

The patient's choice for clinical research. Together for the future of health.

[Synexus @SynexusResearch]

It's #WorldCOPDDay

We invite you to find out more about Chronic Obstructive Pulmonary Disease (COPD) clinical trials here: https://t.co/R7BVU4mZml

*https://t.co/HY0FG0QzKP

[Synexus @SynexusResearch]

Over the next two days we are attending the European Site Solutions Summit at The Tower Hotel in London.

If you would like to take this opportunity to engage or network with our team, please email: [email protected] #SCRS19Europe

[Synexus @SynexusResearch]

We are delighted to be attending the European Site Solutions Summit at The Tower Hotel in London on 18-19 Mar 2019

To discuss how Synexus delivers unparalleled capability, data-driven site selection & proven patient recruitment, please email: [email protected] #SCRS19Europe

[Synexus @SynexusResearch]

We are delighted to be attending the 2019 European Site Solutions Summit at The Tower Hotel in London on 18-19 March 2019.

If you would like to engage or network with our team, please email: [email protected] #SCRS19Europe

[Synexus @SynexusResearch]

In supporting #BrainAwarenessWeek we remain committed to CNS therapeutic area research.
Our global leadership in schizophrenia is well known throughout industry and academia, with 897 CNS studies performed.

Together we make a difference. Learn more at https://t.co/GdmbP0KIFD

[Synexus @SynexusResearch]

Supporting #WorldKidneyDay we continue our commitment to clinical operation to ensure the improvement of kidney and renal disease. We provide customised solutions & result-focused approach to patient enrolment and retention.

To learn more: https://t.co/i3WExjZytv

[Synexus @SynexusResearch]

We’re recognising #WorldKidneyDay & remain committed to the clinical operation to ensure the improvement of kidney & renal disease. We’ve held successful urology trials including benign prostatic hyperplasia, overactive bladder & incontinence.
Learn more: https://t.co/i3WExjZytv

[Synexus @SynexusResearch]

We are acknowledging #glaucomaweek and continue our commitment to the clinical operation with a therapeutic focus on ophthalmology studies, to ensure the improvement of eye health.
Together we make a difference. Learn more at https://t.co/JEhDn1rwTU

[Synexus @SynexusResearch]

We continue to acknowledge #glaucomaweek and remain committed to ensuring the improvement of eye health through both biopharmaceutical, medical device and diagnostic development.

Together we make a difference.

Learn more at https://t.co/JEhDn1rwTU

[Synexus @SynexusResearch]

We continue to support #BrainAwarenessWeek remaining committed to CNS research. With 89% of the Synexus patient community aged 50+, our source of volunteers represent ideal candidates for cognitive health.

Together we make a difference. Learn more at https://t.co/GdmbP0KIFD

[Synexus @SynexusResearch]

We are delighted to be attending the 2nd Global NASH Congress, which will be held in London on 25-26 February.

To discuss how the Synexus model can effectively facilitate the acceleration of NASH candidate development pipelines, please email: [email protected]

[Synexus @SynexusResearch]

We are delighted to be attending the 2nd Global NASH Congress, which will be held in London on 25-26 February.

To discuss how the Synexus model can effectively facilitate the acceleration of NASH candidate development pipelines, please email: [email protected]

[Synexus @SynexusResearch]

SCOPE 2019, February 18 - 21 is where our Chief Medical Officer, Dr Dawie Wessels, will host a luncheon presentation for industry delegates on Tuesday February 19 at 12:45 entitled, Key Learnings from the PROTECT Registry. Book now: https://t.co/GrAlx4gbWw

[Synexus @SynexusResearch]

We are delighted to be attending the 2nd Global NASH Congress, which will be held in London on 25-26 February.

To discuss how the Synexus model can effectively facilitate the acceleration of NASH candidate development pipelines, please email: [email protected]

[Synexus @SynexusResearch]

Feb 18 - 21, discover the Synexus difference at SCOPE 2019. The world’s leading site network organisation that delivers unparalleled capability, data-driven site selection & proven patient recruitment, engagement & retention will be at Booth #405 Book now: https://t.co/GrAlx4gbWw

[Synexus @SynexusResearch]

We are delighted to be attending the 3rd Annual NASH-TAG Conference 2019 in Park City, Utah, US. To discuss how the Synexus model can effectively facilitate the acceleration of NASH candidate development pipelines, please email: [email protected]

#NashTagConf

[Synexus @SynexusResearch]

We are delighted to be attending the 3rd Annual NASH-TAG Conference 2019 in Park City, Utah, US. To discuss how the Synexus model can effectively facilitate the acceleration of NASH candidate development pipelines, please email: [email protected]

#NashTagConf

[Synexus @SynexusResearch]

We are delighted to be attending the 3rd Annual NASH-TAG Conference 2019 in Park City, Utah, US. To discuss how the Synexus model can effectively facilitate the acceleration of NASH candidate development pipelines, please email: [email protected]

#NashTagConf

[Synexus @SynexusResearch]

We are delighted to be attending the 3rd Annual NASH-TAG
Conference 2019 in Park City, Utah, US. To discuss how the Synexus model can effectively facilitate the acceleration of NASH candidate development pipelines, please email: [email protected]

#NashTagConf

[Synexus @SynexusResearch]

Today, we join the rest of the world on World Aids Day to unite in the fight against HIV. Synexus works on studies for various vaccines and infectious diseases including HIV. Together we make a difference.

#WAD2018 #rocktheribbon